ClinicalTrials.govpublic full text
Talimogene Laherparepvec and Pembrolizumab in Treating Patients With Stage III-IV Melanoma
advanced melanoma, recurrent melanoma, stage iii cutaneous melanoma ajcc v7, stage iiia cutaneous melanoma ajcc v7, stage iiib cutaneous melanoma ajcc v7, stage iiic cutaneous melanoma ajcc v7
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 279491
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.